Format

Send to

Choose Destination

See 1 citation found by title matching your search:

J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):e112-e114. doi: 10.1097/QAI.0000000000001863.

Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy.

Author information

1
Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA.
2
Rollins School of Public Health, Emory University, School of Medicine, Atlanta, GA.
3
Division of Infectious Diseases, Northwestern University, Chicago, IL.
4
Division of Infectious Diseases, Brigham and Women's Hospital Boston, Boston, MA.
5
University of Cincinnati Medical Center, Cincinnati, OH.
6
Division of Infectious Diseases, Weill Cornell Medicine, New York, NY.
7
Department of Biostatistics, Center for Biostatistics and AIDS Research, Harvard TH Chan School of Public Health, Boston, MA.
PMID:
30383591
PMCID:
PMC6231952
[Available on 2019-12-15]
DOI:
10.1097/QAI.0000000000001863

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center